TY - JOUR
T1 - Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis
AU - Xu, Xiao Chun
AU - Sneige, Nour
AU - Liu, Xiaoming
AU - Nandagiri, Raju
AU - Lee, J. Jack
AU - Lukmanji, Farzana
AU - Hortobagyi, Gabriel
AU - Lippman, Scott M.
AU - Dhingra, Kapil
AU - Lotan, Reuben
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1997/11/15
Y1 - 1997/11/15
N2 - Some of the nuclear retinoic acid receptors (RARs) α, β, and γ and retinoid X receptors (RXRs) α, β, and γ are thought to mediate the effects of retinoids on cell growth, differentiation, and apoptosis and thereby prevent breast carcinogenesis. We analyzed the expression of mRNAs for the three RARs and RXR-α in histological sections of specimens from 70 breast cancer patients, which included adjacent normal tissue, ductal carcinoma in situ, and invasive cancer, using in situ hybridization. RARs α, β, and γ, and RXR-α were expressed in 98.1, 98.0, 93.0, and 100% of the adjacent normal tissues. Significant decreases in the number of cases expressing RAR- β were observed among ductal carcinoma in situ (83.1%) and invasive carcinomas (51.6%), especially among the poorly differentiated cases (77.4 and 35.7%, respectively). NO relationship was found between the expression of estrogen receptor and RAR-β. These results implicate decreases in RAR-β expression in breast cancer development and suggest that they are independent of estrogen receptor status.
AB - Some of the nuclear retinoic acid receptors (RARs) α, β, and γ and retinoid X receptors (RXRs) α, β, and γ are thought to mediate the effects of retinoids on cell growth, differentiation, and apoptosis and thereby prevent breast carcinogenesis. We analyzed the expression of mRNAs for the three RARs and RXR-α in histological sections of specimens from 70 breast cancer patients, which included adjacent normal tissue, ductal carcinoma in situ, and invasive cancer, using in situ hybridization. RARs α, β, and γ, and RXR-α were expressed in 98.1, 98.0, 93.0, and 100% of the adjacent normal tissues. Significant decreases in the number of cases expressing RAR- β were observed among ductal carcinoma in situ (83.1%) and invasive carcinomas (51.6%), especially among the poorly differentiated cases (77.4 and 35.7%, respectively). NO relationship was found between the expression of estrogen receptor and RAR-β. These results implicate decreases in RAR-β expression in breast cancer development and suggest that they are independent of estrogen receptor status.
UR - http://www.scopus.com/inward/record.url?scp=15644381775&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15644381775&partnerID=8YFLogxK
M3 - Article
C2 - 9371489
AN - SCOPUS:15644381775
SN - 0008-5472
VL - 57
SP - 4992
EP - 4996
JO - Cancer Research
JF - Cancer Research
IS - 22
ER -